Aditxt, Inc.
Acquires, develops, and deploys health technologies to address major health challenges.
ADTX | US
Overview
Corporate Details
- ISIN(s):
- US0070251097
- LEI:
- Country:
- United States of America
- Address:
- 737 N. FIFTH STREET, SUITE 200, 23219 RICHMOND
- Website:
- https://aditxt.com/
Description
Aditxt, Inc. is an innovation company focused on acquiring, developing, and deploying promising health technologies. Its business model involves acquiring disruptive and scalable companies, leveraging its business acceleration platform to drive growth, and monetizing assets through various strategies including mergers, sales, and licenses. The company's portfolio of programs targets significant health challenges. Current programs include Adimune, focused on autoimmunity; Pearsanta, for early cancer detection; and Adivue, for neurological diagnostics. Aditxt also has planned programs and proposed acquisitions in areas such as reproductive health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aditxt, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aditxt, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aditxt, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
